11th EUCLID Platform Seminar

The 11th EUCLID Platform Seminar gathered partners in Bordeaux on December 5, 2025. Focused on challenges of international clinical research in the Global South, the event explored malaria vaccine development and flagship projects like STRIVE and PREVAC.

11th EUCLID Platform Seminar – A Day Dedicated to International Clinical Research!

This Friday, December 5, 2025, we were pleased to bring together partners, researchers, clinicians, and field stakeholders at Les Chantiers de la Garonne in Bordeaux for the 11th EUCLID Platform Seminar.

Theme of this edition: Challenges of International Clinical Research Conducted in the Global South

A unique opportunity to explore the innovations and specificities shaping research projects carried out in collaboration with our international partners.

🔬 On the agenda:

  • Updates from the EUCLID platform, the F-CRIN infrastructure, and European funding programs

  • Presentation of the specific features of clinical research in countries of the Global South

  • Overview of the clinical development of malaria vaccines

  • Focus on several flagship projects supported by EUCLID: STRIVE, PREVAC/PREVAC-UP, OPTIMAD

The day also featured discussions and feedback sessions among experts on best practices and key challenges to strengthen the quality and impact of international clinical studies.

🌍 At EUCLID, we strongly believe in the value of international scientific partnerships to address global health challenges. This seminar marked another step forward in strengthening these collaborations and sharing essential knowledge for medical progress.

👏 Thank you to all speakers, collaborators, and participants of the EUCLID Platform Seminar for this day rich in exchanges and for their commitment to advancing international clinical research together!

   

Other news

Newsletter-Euclid

Newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Newsletter subscription

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.